IL-18-knockout (Il18−/−) mice also showed dyslipidemia, non-alcoholic fatty liver disease (NAFLD), or non-alcoholic steatohepatitis (NASH) [3]. This evidence concerns the gene IL18 and metabolic dysfunction-associated steatohepatitis.